Attention: Our certification management system is getting updated and will be temporarily unavailable, starting on Feb. 10. | LEARN MORE
Longitudinal Assessment References
Due to copyright restrictions, the AOBOG cannot provide most reference materials used for longitudinal assessment. However, a list of the references used for the 2025 longitudinal assessment can be found below. Hyperlinks are provided in teal text where applicable.
Primary OB/GYN (includes all three tracks – OB/GYN, OB only and GYN only)
Track 1: OB/GYN
Quarter 1
- ACOG Clinical Practice Guideline 1: Osteoporosis Prevention, Screening, and Diagnosis
- ACOG Clinical Consensus 4: Urinary Tract Infections in Pregnant Individuals
- ACOG Practice Bulletin 226: Screening for Fetal Chromosomal Abnormalities
- ACOG Committee Opinion 557: Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women
- ACOG Committee Opinion 831: Medically Indicated Late Preterm and Early-Term Deliveries
Quarter 2
- ACOG Clinical Consensus 3: General Approaches to Medical Management of Menstrual Suppression
- ACOG Practice Bulletin 183: Postpartum Hemorrhage
- ACOG Practice Bulletin 203: Chronic Hypertension in Pregnancy
- ACOG Practice Bulletin 228: Management of Symptomatic Uterine Leiomyomas
- ACOG Committee Opinion 603: Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment
- ACOG Committee Opinion 750: Perioperative Pathways: Enhanced Recovery After Surgery
- ACOG Committee Opinion 811: The Initial Reproductive Health Visit
- ACOG Committee Opinion 823: Health Care for Transgender and Gender Diverse Individuals
Quarter 3
- ACOG Clinical Practice Guideline 2: Management of Postmenopausal Osteoporosis
- ACOG Committee Opinion 812: Topical Hemostatic Agents at the Time of Obstetric and Gynecologic Surgery
- ACOG Committee Opinion 828: Indications for Outpatient Antenatal Fetal Surveillance
Track 2: OB only (for physicians who practice only Obstetrics)
Quarter 1
- ACOG Clinical Consensus 4: Urinary Tract Infections in Pregnant Individuals
- ACOG Practice Bulletin 226: Screening for Fetal Chromosomal Abnormalities
- ACOG Committee Opinion 831: Medically Indicated Late Preterm and Early-Term Deliveries
Quarter 2
- ACOG Clinical Practice Guideline 4: Screening and Diagnosis of Mental Health Conditions during Pregnancy and Postpartum
- ACOG Practice Bulletin 183: Postpartum Hemorrhage
- ACOG Practice Bulletin 203: Chronic Hypertension in Pregnancy
Quarter 3
- ACOG Practice Bulletin 221: External Cephalic Version
- ACOG Practice Bulletin 230: Obesity in Pregnancy
- ACOG Committee Opinion 828: Indications for Outpatient Antenatal Fetal Surveillance
Track 3: GYN only (physicians who practice only Gynecology)
Quarter 1
- ACOG Clinical Practice Guideline 1: Osteoporosis Prevention, Screening, and Diagnosis
- ACOG Clinical Consensus 6: Compounded Bioidentical Menopausal Hormone Therapy
- ACOG Practice Bulletin 232: Prevention of Venous Thromboembolism in Gynecologic Surgery
- ACOG Committee Opinion 557: Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women
Quarter 2
- ACOG Clinical Consensus 3: General Approaches to Medical Management of Menstrual Suppression
- ACOG Practice Bulletin 228: Management of Symptomatic Uterine Leiomyomas
- ACOG Committee Opinion 603: Evaluation of Uncomplicated Stress Urinary Incontinence in Women Before Surgical Treatment
- ACOG Committee Opinion 750: Perioperative Pathways: Enhanced Recovery After Surgery
- ACOG Committee Opinion 811: The Initial Reproductive Health Visit
- ACOG Committee Opinion 823: Health Care for Transgender and Gender Diverse Individuals
Quarter 3
- ACOG Clinical Practice Guideline 2: Management of Postmenopausal Osteoporosis
- ACOG Committee Opinion 812: Topical Hemostatic Agents at the Time of Obstetric and Gynecologic Surgery
Subspecialties
Gynecologic Oncology
- Berek and Hacker’s Gynecologic Oncology, 7th (2021)
- Chapter 3, pages 36-60
- Chapter 8, pages 222-308
- Chapter 12, pages 477-503
- The British Journal of Radiology (Sep 2021); Vol. 94, Issue 1125; Implications of the new FIGO staging and the role of imaging in cervical cancer
- Gynecologic Oncology (Mar 2019); Vol. 152, Issue 3: pages 540-547 – Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)
- Gynecologic Oncology (Mar 2021); Vol. 160, Issue 3: pages 817-826 – Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations
- International Journal of Gynaecology and Obstetrics (Oct 2021); Vol. 155, Supplement 1: pages 123-134 – Obesity and gynecological cancers: A toxic relationship
- Journal of Gynecologic Oncology (Sep 2020); Vol. 31, Issue 5; Vulvar melanoma: an analysis of prognostic factors and treatment patterns; pg. e66
- Molecular Cancer (Jan 2019); Vol. 18, Number 10; Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- National Comprehensive Cancer Network (Updated 2024); Cervical cancer
- National Comprehensive Cancer Network (Updated 2024); Ovarian cancer/fallopian tube cancer/primary peritoneal cancer
- National Comprehensive Cancer Network (Updated 2024); Uterine cancer
- Neurology (Apr 2021); Vol. 96, Issue 16: pages 754-766 – Neurologic adverse events of immune checkpoint inhibitors: a systematic review; pg. 754-766
- The New England Journal of Medicine (Dec 2011); Vol. 365, Issue 26: pages 2473-2483 – Incorporation of bevacizumab in the primary treatment of ovarian cancer
- The New England Journal of Medicine (Jun 2023); Vol. 388, Issue 23: pages 2145-2158 – Dostarlimab for primary advanced or recurrent endometrial cancer; pg. 2145-2158
- Oxford Handbook of Medical Statistics, 1st ed. (2011); pg. 248
- Principles and Practice of Gynecologic Oncology, 7th (2017)
- Chapter 4, pages 66-78
- Chapter 7, pages 114-129
- Chapter 15, pages 345-362
- Chapter 24, pages 706-723
- Radiology and Oncology (Dec 2022); Vol. 56, Issue 4: pages 453-460 – FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: Comparison with MRI
- StatPearls (Updated Jun 2023); Pembrolizumab
Maternal Fetal Medicine
- ACOG Practice Bulletin 171: Management of Preterm Labor
- ACOG Practice Bulletin 181: Prevention of Rh D Alloimmunization
- ACOG Practice Bulletin 192: Management of Alloimmunization During Pregnancy
- ACOG Practice Bulletin 217: Prelabor Rupture of Membranes
- ACOG Practice Bulletin 234: Prediction and Prevention of Spontaneous Preterm Birth
- ACOG Committee Opinion 711: Opioid Use and Opioid Use Disorder in Pregnancy
- Addiction (Dec 2016); Vol. 111, Issue 12: pages 2115-2128 – Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child; pg. 2115-2128
- American Journal of Obstetrics & Gynecology (Jun 2015); Vol. 212, Issue 6: pages 697-710 – Society for Maternal-Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia–diagnosis and management
- American Journal of Obstetrics & Gynecology (Aug 2015); Vol. 213, Issue 5: pages 615-619 – SMFM Consult Series #37: diagnosis and management of vasa previa
American Journal of Obstetrics & Gynecology (Oct 2018); Vol. 219, Issue 4: pages B2-B8 – SMFM Consult Series #46: evaluation and management of polyhydramnios; pg. B2-B8 - BMJ Case Reports (Feb 2023); Vol. 16, Issue 2; Diabetic ketoacidosis in pregnancy
- Clinical Medicine (Sep 2021); Vol. 21, Issue 5: pages e438-e440 – Metabolic emergencies in pregnancy
- Current Obstetrics and Gynecology Reports (Jan 2016); Vol. 5, Issue 3: pages 257-263 – Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment
- Drug and Alcohol Dependence (May 2003); Vol. 70, Suppl. 2: pages S87-S101 – Use of buprenorphine in pregnancy: patient management and effects on the neonate
- Journal of Emergencies, Trauma, and Shock (May 2009); Vol. 2, Issue 2: pages 124-128 – Emergency management of decompensated peripartum cardiomyopathy
- Seminars in Perinatology (Aug 2013); Vol. 37, Issue 4: pages 267-273 – Diabetes ketoacidosis in pregnancy
- StatPearls (Updated Jul 2023); Peripartum cardiomyopathy
Reproductive Endocrinology & Infertility
- ACOG Practice Bulletin 193: Tubal Ectopic Pregnancy
- ACOG Committee Opinion 728: Müllerian agenesis: diagnosis, management, and treatment
- Clinical Gynecologic Endocrinology and Infertility, 8th ed. (2011), pages 483-484
- Current Opinion in Obstetrics and Gynecology (Aug 2023); Vol. 35, Issue 4: pages 279-287 – An update and review of nontubal ectopic pregnancy management
- Fairfax Cryobank (Updated 2020); CMV and pregnancy
- Fairfax Cryobank (Updated 2020); It is time to consider expanded genetic carrier testing for all sperm donors
- Fertility and Sterility (Aug 2010); Vol. 94, Issue 3: pages 888-899 – A randomized clinical trial to evaluate optimal treatment for unexplained infertility: The fast track and standard treatment (FASTT) trial
- Fertility and Sterility (Jun 2018); Vol. 109, Issue 6: pages 993-999 – Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline
- Fertility and Sterility (Jan 2020); Vol. 113, Issue 1: pages 66-70 – Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion
- Fertility and Sterility (Sep 2020); Vol. 114, Issue 3: page e431 – Efficacy of PGT-A with a single blastocyst
- Fertility and Sterility (Nov 2023); Vol. 120, Issue 5; pages 973-982 – Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion
- Gynecologic Endocrinology and Infertility, 9th (2019) – Chapter 10, pages 343-394
- Gynecology and Minimally Invasive Therapy (Apr 2023); Vol. 12, Issue 2: pages 64-71 – Cesarean scar pregnancy: current understanding and treatment including role of minimally invasive surgical techniques
- Human Reproduction (Feb 2017); Vol. 32, Issue 2: pages 315-324 – World Endometriosis Society consensus on the classification of endometriosis
- Human Reproduction Update (Nov 2017); Vol. 23, Issue 6: pages 660-680 – The diagnosis of male infertility: An analysis of the evidence to support the development of global WHO guidance–challenges and future research opportunities
- Human Reproduction (May 2021); Vol. 36, Issue 6: pages 1702-1710 – The use of expanded carrier screening of gamete donors
- Human Reproduction Open (Feb 2022); Vol. 2022, Issue 2 – ESHRE guideline: endometriosis
- JBRA Assisted Reproduction (Jan 2022); Vol. 26, Issue 1: pages 22-27 – Comparative analysis of the pregnancy rate via in vitro fertilization vs. previous artificial insemination in patients with unexplained infertility
- Journal of Assisted Reproduction and Genetics (Jan 2019); Vol. 36, Issue 1: pages 165-172 – Rates of live birth after mosaic embryo transfer compared with euploid embryo transfer
- The Journal of Clinical Endocrinology and Metabolism (Nov 2020); Vol. 105, Issue 11: pages 3361-3373 – Anti-Mullerian hormone and ovarian reserve: update on assessing ovarian function
- Journal of Healthcare Engineering (Mar 2022); Vol. 2022 – The effects of letrozole and metformin combined with targeted nursing care on ovarian function, LH, and FSH in infertility patients with polycystic ovary syndrome
- Journal of Obstetrics and Gynaecology (2015); Vol. 35, Issue 6: pages 547-550 – Management of hydrosalpinx before IVF: a literature review
- Journal of Obstetrics and Gynaecology Research (Oct 2021); Vol. 47, Issue 10: pages 3583-3589 – Letrozole as first-line drug for ovulation induction in treatment-naïve infertile polycystic ovarian syndrome women
- The Journal of Urology (Jan 2021); Vol. 205, Issue 1: pages 36-43 – Diagnosis and treatment of infertility in men: AUA/ASRM Guideline Part I
- The Journal of Urology (Jan 2021); Vol. 205, Issue 1: pages 44-51 – Diagnosis and treatment of infertility in men: AUA/ASRM Guideline Part II
- The New England Journal of Medicine (Jul 2014); Vol. 317, Issue 2: pages 1191-129 – Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
- OBG Project (Updated Mar 2022); ASRM committee opinion on the evaluation and treatment of recurrent pregnancy loss
- Reproductive Biology and Endocrinology (Aug 2011); Vol. 9, Issue 115 – The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age
- Reproductive Medicine and Biology (Aug 2023); Vol. 22, Issue 1 – Prevalence, definition, and etiology of cesarean scar defect and treatment of cesarean scar disorder: a narrative review
- Therapeutic Advances in Endocrinology and Metabolism (Jan 2018); Vol. 9, Issue 1: pages 33-40 – Current best practice in the management of Turner syndrome
- Williams Gynecology, 4th ed. (2020) – Chapter 17: Amenorrhea
Urogynecology & Reconstructive Pelvic Surgery (formerly FPMRS)
- American Journal of Obstetrics & Gynecology (Jun 2019); Vol. 221, Issue 5: pages 517.e1-517.e9 – A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain
- American Journal of Obstetrics & Gynecology (Sep 2022); Vol. 227, Issue 3: pages 471.e1-471.e7 – Cost-effectiveness of prophylactic retropubic sling at the time of vaginal prolapse surgery
- Female Pelvic Medicine & Reconstructive Surgery (Mar 2021); Vol. 27, Issue 3: pages 202-2027 – Twice-daily nitrofurantoin administration following short-term transurethral catheterization after pelvic reconstructive surgery: a randomized clinical trial
- The New England Journal of Medicine (Mar 2022); Vol. 386, Issue 13: pages 1230-1243 – Single-incision mini-slings for stress urinary incontinence in women